Reversal of Preneoplastic Metaplasia in the Stomach With MEK Inhibitor

Clinical trial NCT04454476 · UNKNOWN

Trial details

NCT number: NCT04454476
Sponsor: Vanderbilt-Ingram Cancer Center
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Gastric Cancer Metaplasia Stage I Gastric Cancer Initial-onset Gastric Cancer

Start date: 2022-11-09
Primary completion: 2024-12-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.